Whether you choose to file a patent application or keep a new invention secret, it’s crucial to take steps to minimise the risks of disclosure. Rose-Marie Ehanno explains how to keep patentable inventions confidential.
Must a compound be shown to be suitable for each disease for first medical use claims to be sufficiently disclosed in applications for European patents, asks Matthieu Boulard.
With the imminent entry into force of the Unified Patent Court Agreement, the countdown has begun to opt-out of the jurisdiction of the new European court. Marie-Noëlle de la Fouchardière explains what can be opted out, by whom and how to simplify the management of opt-out declarations.
In a recent webinar on best practices for European patents, Novagraaf’s Dr Kate McNamara joined experts from Questel to discuss the new European patenting landscape. Here, we summarise some of the key points discussed.
Patents to protect innovation are applied for and owned only by their ‘human’ inventor, so what happens if a product is produced entirely and autonomously by a highly advanced computer? This question has been at the heart of a number of proceedings before patent offices around the world, including the EPO, as Volha Parfenchyk explains.
In June 2022, the World Trade Organization approved the temporary lifting of patents for COVID-19 vaccines. Robert Balsters explains what this means in practice.
When it comes to protecting software innovation, copyright can appear to be the only applicable right. Sylvain Chaffraix explains how to include software patents in innovation management strategies in Europe.
With the Unitary Patent and Unified Patent Court system on the horizon, the first question for European patent rights holders is whether to opt-out from the jurisdiction of the UPC before the system comes into force.
When businesses merge with or acquire other businesses, the challenge for IP professionals doesn’t stop once the deal is complete. For IP rights to be properly updated and maintained, the question of how to brand and structure the newly merged business first needs to be addressed.
Establishing valid priority claims can be challenging for co-applicants in Europe, as Stéphanie Landais-Patarin explains.
The route to implementation of the proposed unitary patent and Unified Patent Court system has been far from easy. With it now projected to come into effect before the end of 2022, we set out the answers to some frequently asked questions in our latest white paper 'The Unitary Patent: A practical guide'.
PPH programmes can help patent applicants to accelerate the grant of a patent application in a second patent office. Emmanuelle Laude-Duval explains the opportunities and benefits of the system.